Clinical Immunology Service

Organisational unit: Department

Publications

  1. Published
  2. Published
  3. Published

    What is the significance of monoclonal gammopathy of undetermined significance?

    Catherine Atkin, Alex Richter & Elizabeth Sapey, Oct 2018, In: Clinical Medicine. 18, 5, p. 391-396 6 p.

    Research output: Contribution to journalReview articlepeer-review

  4. E-pub ahead of print
  5. Published
  6. Published
  7. Published

    Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML

    Sylvie Freeman & 4 others, , 1 Apr 2019, In: The Journal of Experimental Medicine. 216, 4, p. 966-981 16 p.

    Research output: Contribution to journalArticlepeer-review

  8. Published
  9. Published

    Role of minimal (measurable) residual disease assessment in older patients with acute myeloid leukemia

    Sylvie Freeman, 1 Jul 2018, In: Cancers. 10, 7, 15 p., 215.

    Research output: Contribution to journalReview articlepeer-review

  10. E-pub ahead of print
  11. E-pub ahead of print

    In-house age-specific reference ranges for free light chains measured on the SPAPlus® analyser

    Adrian Shields, 18 Dec 2019, (E-pub ahead of print) In: Annals of Clinical Biochemistry.

    Research output: Contribution to journalArticlepeer-review

  12. Published
  13. E-pub ahead of print
  14. E-pub ahead of print
  15. Published
  16. Published

    The benefits of physical exercise for the health of the pancreatic β-cell: a review of the evidence

    Mark Drayson, Jonathan Barlow, Thomas Solomon & Parth Narendran, 1 Apr 2020, In: Experimental Physiology. 105, 4, p. 579-589 11 p.

    Research output: Contribution to journalReview articlepeer-review

  17. Published

    The evolution of cellular deficiency in GATA2 mutation

    & 13 others, , Gideon Hirschfield, Alex Richter, 6 Feb 2014, In: Blood. 123, 6, p. 863-74 12 p.

    Research output: Contribution to journalArticlepeer-review

  18. E-pub ahead of print

    How we use molecular minimal residual disease (MRD) testing in acute myeloid leukaemia (AML).

    Sylvie Freeman, Oct 2020, (E-pub ahead of print) In: British Journal of Haematology.

    Research output: Contribution to journalArticlepeer-review

  19. Published

    Molecular MRD status and outcome after transplantation in NPM1-mutated AML

    Robert Hills, Sylvie Freeman & 19 others, , Igor Novitzky Basso, 27 Feb 2020, In: Blood. 135, 9, p. 680-688 9 p.

    Research output: Contribution to journalArticlepeer-review

  20. Published
Previous 1 2 3 4 Next